CTNNB1 and neoplasm: Based on a large proportion of samples being CTNNB1 mutation negative in both plasma and tumor tissue, the agreement between plasma and tissue mutational status was 91.7% (kappa value 0.53 (0.20–0.85), P = 0.0007).